Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Sep 10, 2018

---

• Poly (ADP-ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: A Drug Class Review.  
  Ringley J Tanner et al. P & T : a peer-reviewed journal for formulary management 2018 Sep (9) 549-556
• Finding Pediatric Cancer Genomic Data through PGDI  
  NCI, September 2018
• Unraveling the Mystery of What Gives Exceptional Responders Their Superpower 
  J Cavallo, ASCO Post, August 2018
• Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.  
  Zhang Xuehong et al. PLoS medicine 2018 Sep 15(9) e1002644
• BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.  
  Gross Amy L et al. JAMA 2018 Aug 320(6) 597-598
• Broad Genomic Testing in NSCLC: No Survival Benefit?  
  et al. Cancer discovery 2018 Aug
• Cancer genetics, precision prevention and a call to action.  
  Turnbull Clare et al. Nature genetics 2018 Sep 50(9) 1212-1218
• Family History and Cancer
  CDC Division of Cancer Control and Prevention, 2018
• Genomic Profiling and Potentially Targetable Alterations in Pancreatic Ductal Adenocarcinoma.  
  Gleeson Ferga C et al. Current treatment options in gastroenterology 2018 Sep
• Genomic Prostate Score, PI-RADSv2, and Progression in Men with Prostate Cancer on Active Surveillance.  
  Kornberg Zachary et al. The Journal of urology 2018 Sep